CarMax’s Debt Overview
Over the past three months, shares of CarMax (NYSE:KMX) increased by 0.31%. Before we understand the importance of debt, let us look at how much debt CarMax has.
JP Morgan Upgrades CarMax to Overweight, Raises Price Target to $160
JP Morgan analyst Rajat Gupta upgrades CarMax (NYSE:KMX) from Neutral to Overweight and raises the price target from $140 to $160.
Battered Autohome Sees Light At The End Of The Tunnel
Key Takeaways:
Leading Chinese online auto company Autohome says its revenue fell 24% in the third quarter, dragged down by a 50% decline in spending by car manufacturers
The company sees global auto sector returning to more normal conditions in the second half of next year as chip shortages ease
By Doug Young
Recap: CarMax Q2 Earnings
CarMax(NYSE:KMX) stock fell by 0.61% on Friday after the company reported its Q2 earnings results on Thursday, September 30, 2021 at 06:50 AM.
Here's what investors need to know about the announcement.
Guggenheim Downgrades CarMax To Neutral
Guggenheim analyst Ali Faghri downgraded CarMax Inc (NYSE: KMX) to Neutral from Buy without a price target.
Faghri continues to have a positive medium- to long-term view on the company and its ability to be an omnichannel leader.
10 Consumer Discretionary Stocks Showing Unusual Options Activity In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
Merck Announcement Helps Prompt Positive Pre-Market Price Moves
The new quarter appears to be starting off on a slightly higher note as futures are pointing to a positive opening.
Guggenheim Downgrades CarMax to Neutral
Guggenheim analyst Ali Faghri downgrades CarMax (NYSE:KMX) from Buy to Neutral.
RBC Capital Maintains Outperform on CarMax, Lowers Price Target to $156
RBC Capital maintains CarMax (NYSE:KMX) with a Outperform and lowers the price target from $160 to $156.